1
|
Werner M, Brinkhofer J, Hammermüller L, Heim T, Pham TL, Huber J, Klein C, Thomas F. Peptide Boronic Acids by Late-Stage Hydroboration on the Solid Phase. ADVANCED SCIENCE (WEINHEIM, BADEN-WURTTEMBERG, GERMANY) 2024:e2400640. [PMID: 38810019 DOI: 10.1002/advs.202400640] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/12/2024] [Revised: 05/15/2024] [Indexed: 05/31/2024]
Abstract
Organoboron compounds have a wide range of applications in numerous research fields, and metmhods to incorporate them in biomolecules are much sought after. Here, on-resin chemical syntheses of aliphatic and vinylogous peptide boronic acids are presented by transition metal-catalyzed late-stage hydroboration of alkene and alkyne groups in peptides and peptoids, for example on allyl- and propargylglycine residues, using readily available chemicals. These methods yield peptide boronic acids with much shorter linkers than previously reported on-resin methods. Furthermore, the methods are regio- and stereoselective, compatible with all canonical amino acid residues and can be applied to short, long, and in part even "difficult" peptide sequences. In a feasibility study, the protected peptide vinylboronic acids are further derivatized by the Petasis reaction using salicylaldehyde derivatives. The ability of the obtained peptide boronic acids to reversibly bind to carbohydrates is demonstrated in a catch-release model experiment using a fluorescently labeled peptide boronic acid on cross-linked dextran beads. In summary, this highlights the potential of the target compounds for drug discovery, glycan-specific target recognition, controlled release, and diagnostics.
Collapse
Affiliation(s)
- Marius Werner
- Institute of Organic Chemistry, Heidelberg University, Im Neuenheimer Feld 270, 69120, Heidelberg, Germany
- Medicinal Chemistry, Institute of Pharmacy and Molecular Biotechnology (IPMB), Heidelberg University, Im Neuenheimer Feld 364, 69120, Heidelberg, Germany
| | - Julian Brinkhofer
- Institute of Organic Chemistry, Heidelberg University, Im Neuenheimer Feld 270, 69120, Heidelberg, Germany
| | - Leon Hammermüller
- Institute of Organic Chemistry, Heidelberg University, Im Neuenheimer Feld 270, 69120, Heidelberg, Germany
| | - Thomas Heim
- Institute of Organic Chemistry, Heidelberg University, Im Neuenheimer Feld 270, 69120, Heidelberg, Germany
| | - Truc Lam Pham
- Institute of Organic Chemistry, Heidelberg University, Im Neuenheimer Feld 270, 69120, Heidelberg, Germany
| | - Jonas Huber
- Institute of Organic Chemistry, Heidelberg University, Im Neuenheimer Feld 270, 69120, Heidelberg, Germany
| | - Christian Klein
- Medicinal Chemistry, Institute of Pharmacy and Molecular Biotechnology (IPMB), Heidelberg University, Im Neuenheimer Feld 364, 69120, Heidelberg, Germany
| | - Franziska Thomas
- Institute of Organic Chemistry, Heidelberg University, Im Neuenheimer Feld 270, 69120, Heidelberg, Germany
| |
Collapse
|
2
|
Pal S, Openy J, Krzyzanowski A, Noisier A, ‘t Hart P. On-Resin Photochemical Decarboxylative Arylation of Peptides. Org Lett 2024; 26:2795-2799. [PMID: 37819674 PMCID: PMC11019635 DOI: 10.1021/acs.orglett.3c03070] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2023] [Indexed: 10/13/2023]
Abstract
Here we describe the application of photochemical decarboxylative arylation as a late-stage functionalization reaction for peptides. The reaction uses redox-active esters of aspartic acid and glutamic acid on the solid phase to provide analogues of aromatic amino acids. By using aryl bromides as arylation reagents, a wide variety of amino acids can be accessed without having to synthesize them individually in solution. The reaction is compatible with proteinogenic amino acids and was used to perform a structure-activity relationship study of a PRMT5 binding peptide.
Collapse
Affiliation(s)
- Sunit Pal
- Chemical
Genomics Centre, Max Planck Institute of
Molecular Physiology, 44227 Dortmund, Germany
| | - Joseph Openy
- Chemical
Genomics Centre, Max Planck Institute of
Molecular Physiology, 44227 Dortmund, Germany
| | - Adrian Krzyzanowski
- Department
of Chemical Biology, Max Planck Institute
of Molecular Physiology, 44227 Dortmund, Germany
| | - Anaïs Noisier
- Medicinal
Chemistry, Research and Early Development Cardiovascular, Renal and
Metabolism BioPharmaceutical R&D, AstraZeneca, 431 83 Gothenburg, Sweden
| | - Peter ‘t Hart
- Chemical
Genomics Centre, Max Planck Institute of
Molecular Physiology, 44227 Dortmund, Germany
| |
Collapse
|
3
|
Delgado JAC, Tian YM, Marcon M, König B, Paixão MW. Side-Selective Solid-Phase Metallaphotoredox N(in)-Arylation of Peptides. J Am Chem Soc 2023; 145:26452-26462. [PMID: 37976043 DOI: 10.1021/jacs.3c10792] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2023]
Abstract
Postsynthetic diversification of peptides through selective modification of endogenous amino acid side chains has enabled significant advances in peptide drug discovery while expanding the biological and medical chemistry space. However, current tools have been focused on the modification of reactive polar and ionizable side chains, whereas the decoration of aromatic systems (e.g., the N(in) of the tryptophan) has been a long-standing challenge. Here, we introduce metallaphotocatalysis in solid-phase peptide synthesis for the on-resin orthogonal N-arylation of relevant tryptophan-containing peptides. The protocol allows the chemoselective introduction of a new C(sp2)-N bond at the N(in) of tryptophan in biologically active protected peptide sequences in the presence of native redox-sensitive side chains. The fusion of metallaphotocatalysis with solid-phase peptide synthesis opens new perspectives in diversifying native amino acid side chains.
Collapse
Affiliation(s)
- José A C Delgado
- Laboratory for Sustainable Organic Synthesis and Catalysis, Department of Chemistry, Federal University of São Carlos─UFSCar, Rodovia Washington Luís, km 235, SP-310, São Carlos, São Paulo 13565-905, Brazil
- Institute of Organic Chemistry, University of Regensburg, 93040 Regensburg, Germany
| | - Ya-Ming Tian
- Institute of Organic Chemistry, University of Regensburg, 93040 Regensburg, Germany
| | - Michela Marcon
- Institute of Organic Chemistry, University of Regensburg, 93040 Regensburg, Germany
| | - Burkhard König
- Institute of Organic Chemistry, University of Regensburg, 93040 Regensburg, Germany
| | - Márcio W Paixão
- Laboratory for Sustainable Organic Synthesis and Catalysis, Department of Chemistry, Federal University of São Carlos─UFSCar, Rodovia Washington Luís, km 235, SP-310, São Carlos, São Paulo 13565-905, Brazil
| |
Collapse
|
4
|
Hickey J, Sindhikara D, Zultanski SL, Schultz DM. Beyond 20 in the 21st Century: Prospects and Challenges of Non-canonical Amino Acids in Peptide Drug Discovery. ACS Med Chem Lett 2023; 14:557-565. [PMID: 37197469 PMCID: PMC10184154 DOI: 10.1021/acsmedchemlett.3c00037] [Citation(s) in RCA: 19] [Impact Index Per Article: 19.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2023] [Accepted: 03/29/2023] [Indexed: 05/19/2023] Open
Abstract
Life is constructed primarily using a toolbox of 20 canonical amino acids-relying upon these building blocks for the assembly of proteins and peptides that regulate nearly every cellular task, including cell structure, function, and maintenance. While Nature continues to be a source of inspiration for drug discovery, medicinal chemists are not beholden to only 20 canonical amino acids and have begun to explore non-canonical amino acids (ncAAs) for the construction of designer peptides with improved drug-like properties. However, as our toolbox of ncAAs expands, drug hunters are encountering new challenges in approaching the iterative peptide design-make-test-analyze cycle with a seemingly boundless set of building blocks. This Microperspective focuses on new technologies that are accelerating ncAA interrogation in peptide drug discovery (including HELM notation, late-stage functionalization, and biocatalysis) while shedding light on areas where further investment could not only accelerate the discovery of new medicines but also improve downstream development.
Collapse
Affiliation(s)
- Jennifer
L. Hickey
- Department
of Medicinal Chemistry, Merck & Co.,
Inc., Kenilworth, New Jersey 07033, United States
| | - Dan Sindhikara
- Department
of Modeling and Informatics, Merck &
Co., Inc., Kenilworth, New Jersey 07033, United States
| | - Susan L. Zultanski
- Department
of Process Research & Development, Merck
& Co., Inc., Rahway, New Jersey 07065, United States
| | - Danielle M. Schultz
- Department
of Process Research & Development, Merck
& Co., Inc., Rahway, New Jersey 07065, United States
| |
Collapse
|
5
|
Twitty JC, Hong Y, Garcia B, Tsang S, Liao J, Schultz DM, Hanisak J, Zultanski SL, Dion A, Kalyani D, Watson MP. Diversifying Amino Acids and Peptides via Deaminative Reductive Cross-Couplings Leveraging High-Throughput Experimentation. J Am Chem Soc 2023; 145:5684-5695. [PMID: 36853652 PMCID: PMC10117303 DOI: 10.1021/jacs.2c11451] [Citation(s) in RCA: 14] [Impact Index Per Article: 14.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/01/2023]
Abstract
A deaminative reductive coupling of amino acid pyridinium salts with aryl bromides has been developed to enable efficient synthesis of noncanonical amino acids and diversification of peptides. This method transforms natural, commercially available lysine, ornithine, diaminobutanoic acid, and diaminopropanoic acid to aryl alanines and homologated derivatives with varying chain lengths. Attractive features include ability to transverse scales, tolerance of pharma-relevant (hetero)aryls and biorthogonal functional groups, and the applicability beyond monomeric amino acids to short and macrocyclic peptide substrates. The success of this work relied on high-throughput experimentation to identify complementary reaction conditions that proved critical for achieving the coupling of a broad scope of aryl bromides with a range of amino acid and peptide substrates including macrocyclic peptides.
Collapse
Affiliation(s)
- J. Cameron Twitty
- Department of Chemistry & Biochemistry, University of Delaware, Newark, Delaware 19716, United States
| | - Yun Hong
- Department of Chemistry & Biochemistry, University of Delaware, Newark, Delaware 19716, United States
| | - Bria Garcia
- Department of Chemistry & Biochemistry, University of Delaware, Newark, Delaware 19716, United States
| | - Stephanie Tsang
- Department of Chemistry & Biochemistry, University of Delaware, Newark, Delaware 19716, United States
| | - Jennie Liao
- Department of Chemistry & Biochemistry, University of Delaware, Newark, Delaware 19716, United States
| | - Danielle M. Schultz
- Department of Process Research & Development, Merck & Co., Inc., MRL, Rahway, NJ 07065, United States
| | - Jennifer Hanisak
- Discovery Chemistry, Merck & Co., Inc., Kenilworth, New Jersey 07033, United States
| | - Susan L. Zultanski
- Department of Process Research & Development, Merck & Co., Inc., MRL, Rahway, NJ 07065, United States
| | - Amelie Dion
- Department of Process Research & Development, Merck & Co., Inc., MRL, Rahway, NJ 07065, United States
| | - Dipannita Kalyani
- Discovery Chemistry, Merck & Co., Inc., Kenilworth, New Jersey 07033, United States
| | - Mary P. Watson
- Department of Chemistry & Biochemistry, University of Delaware, Newark, Delaware 19716, United States
| |
Collapse
|
6
|
Elbaum MB, Elkhalifa MA, Molander GA, Chenoweth DM. Solid-Phase Photochemical Peptide Homologation Cyclization. Org Lett 2022; 24:5176-5180. [PMID: 35816696 PMCID: PMC10435287 DOI: 10.1021/acs.orglett.2c02012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
Forging new C(sp3)-C(sp3) bonds to central positions within a peptide backbone is critical for the development of new therapeutics and chemical probes. Currently, there are no methods for decarboxylating Asp and Glu side chains solid-phase photochemically or using such radicals to form peptide macrocycles. Herein, electron-donor-acceptor complexes between Hantzsch ester and on-resin peptide N-hydroxyphthalimide radical precursors are used to access these radicals, demonstrated with two-carbon homologations and homologation cyclizations of Atosiban and RGDf.
Collapse
Affiliation(s)
- Michael B Elbaum
- Department of Chemistry, University of Pennsylvania, 231 South 34th Street, Philadelphia, Pennsylvania 19104-6323, United States
| | - Mahmoud A Elkhalifa
- Department of Chemistry, University of Pennsylvania, 231 South 34th Street, Philadelphia, Pennsylvania 19104-6323, United States
| | - Gary A Molander
- Department of Chemistry, University of Pennsylvania, 231 South 34th Street, Philadelphia, Pennsylvania 19104-6323, United States
| | - David M Chenoweth
- Department of Chemistry, University of Pennsylvania, 231 South 34th Street, Philadelphia, Pennsylvania 19104-6323, United States
| |
Collapse
|